Hi-Tech Pharmaceuticals Inc. argues that FDA must follow the rulemaking process if it intends to ban the use of DMAA in dietary supplements, saying the agency used a “campaign of intimidation” to force firms to cease manufacturing products with the ingredient.
Hi-Tech is litigating to stop FDA’s enforcement against products containing dimethylamylamine, or DMAA, an ingredient used primarily in strength training...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?